Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Prostate cancer-specific thermo-responsive polymer-coated iron oxide nanoparticles.

Wadajkar AS, Menon JU, Tsai YS, Gore C, Dobin T, Gandee L, Kangasniemi K, Takahashi M, Manandhar B, Ahn JM, Hsieh JT, Nguyen KT.

Biomaterials. 2013 May;34(14):3618-25. doi: 10.1016/j.biomaterials.2013.01.062. Epub 2013 Feb 15.

PMID:
23419645
2.

Dual-responsive polymer-coated iron oxide nanoparticles for drug delivery and imaging applications.

Sundaresan V, Menon JU, Rahimi M, Nguyen KT, Wadajkar AS.

Int J Pharm. 2014 May 15;466(1-2):1-7. doi: 10.1016/j.ijpharm.2014.03.016. Epub 2014 Mar 5.

3.

Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.

Ding C, Wu K, Wang W, Guan Z, Wang L, Wang X, Wang R, Liu L, Fan J.

Oncotarget. 2017 Jan 17;8(3):4718-4729. doi: 10.18632/oncotarget.13578.

4.

Cellular level loading and heating of superparamagnetic iron oxide nanoparticles.

Kalambur VS, Longmire EK, Bischof JC.

Langmuir. 2007 Nov 20;23(24):12329-36. Epub 2007 Oct 26.

PMID:
17960940
5.

Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy.

Purushotham S, Chang PE, Rumpel H, Kee IH, Ng RT, Chow PK, Tan CK, Ramanujan RV.

Nanotechnology. 2009 Jul 29;20(30):305101. doi: 10.1088/0957-4484/20/30/305101. Epub 2009 Jul 7.

PMID:
19581698
6.

A prostate cancer-targeted polyarginine-disulfide linked PEI nanocarrier for delivery of microRNA.

Zhang T, Xue X, He D, Hsieh JT.

Cancer Lett. 2015 Sep 1;365(2):156-65. doi: 10.1016/j.canlet.2015.05.003. Epub 2015 Jun 6.

PMID:
26054847
7.

Temperature-sensitive polymer-coated magnetic nanoparticles as a potential drug delivery system for targeted therapy of thyroid cancer.

Koppolu B, Bhavsar Z, Wadajkar AS, Nattama S, Rahimi M, Nwariaku F, Nguyen KT.

J Biomed Nanotechnol. 2012 Dec;8(6):983-90.

PMID:
23030006
8.

Efficient in vitro labeling of human prostate cancer cells with superparamagnetic iron oxide nanoparticles.

Jiang J, Chen Y, Zhu Y, Yao X, Qi J.

Cancer Biother Radiopharm. 2011 Aug;26(4):461-7. doi: 10.1089/cbr.2010.0934. Epub 2011 Aug 3.

PMID:
21812654
9.

Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo.

Lee H, Yu MK, Park S, Moon S, Min JJ, Jeong YY, Kang HW, Jon S.

J Am Chem Soc. 2007 Oct 24;129(42):12739-45. Epub 2007 Sep 25.

PMID:
17892287
10.

Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer.

Sterenczak KA, Meier M, Glage S, Meyer M, Willenbrock S, Wefstaedt P, Dorsch M, Bullerdiek J, Murua Escobar H, Hedrich H, Nolte I.

BMC Cancer. 2012 Jul 11;12:284.

11.

Multifunctional particles for melanoma-targeted drug delivery.

Wadajkar AS, Bhavsar Z, Ko CY, Koppolu B, Cui W, Tang L, Nguyen KT.

Acta Biomater. 2012 Aug;8(8):2996-3004. doi: 10.1016/j.actbio.2012.04.042. Epub 2012 May 3.

12.

Polymeric nanoparticles for targeted radiosensitization of prostate cancer cells.

Menon JU, Tumati V, Hsieh JT, Nguyen KT, Saha D.

J Biomed Mater Res A. 2015 May;103(5):1632-9. doi: 10.1002/jbm.a.35300. Epub 2014 Aug 14.

13.

Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.

Johannsen M, Thiesen B, Jordan A, Taymoorian K, Gneveckow U, Waldöfner N, Scholz R, Koch M, Lein M, Jung K, Loening SA.

Prostate. 2005 Aug 1;64(3):283-92.

PMID:
15726645
14.

Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.

Li FR, Yan WH, Guo YH, Qi H, Zhou HX.

Int J Hyperthermia. 2009 Aug;25(5):383-91. doi: 10.1080/02656730902834949.

PMID:
19391033
15.

Multimodal tumor imaging by iron oxides and quantum dots formulated in poly (lactic acid)-D-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles.

Tan YF, Chandrasekharan P, Maity D, Yong CX, Chuang KH, Zhao Y, Wang S, Ding J, Feng SS.

Biomaterials. 2011 Apr;32(11):2969-78. doi: 10.1016/j.biomaterials.2010.12.055. Epub 2011 Jan 22.

PMID:
21257200
16.

Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging.

Serda RE, Adolphi NL, Bisoffi M, Sillerud LO.

Mol Imaging. 2007 Jul-Aug;6(4):277-88.

PMID:
17711783
17.

Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique.

Johannsen M, Gneveckow U, Eckelt L, Feussner A, Waldöfner N, Scholz R, Deger S, Wust P, Loening SA, Jordan A.

Int J Hyperthermia. 2005 Nov;21(7):637-47.

PMID:
16304715
18.

Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents.

Lartigue L, Hugounenq P, Alloyeau D, Clarke SP, Lévy M, Bacri JC, Bazzi R, Brougham DF, Wilhelm C, Gazeau F.

ACS Nano. 2012 Dec 21;6(12):10935-49. doi: 10.1021/nn304477s. Epub 2012 Nov 29.

PMID:
23167525
19.

Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles.

Yu MK, Kim D, Lee IH, So JS, Jeong YY, Jon S.

Small. 2011 Aug 8;7(15):2241-9. doi: 10.1002/smll.201100472. Epub 2011 Jun 7.

PMID:
21648076
20.

Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice.

Chanda N, Kan P, Watkinson LD, Shukla R, Zambre A, Carmack TL, Engelbrecht H, Lever JR, Katti K, Fent GM, Casteel SW, Smith CJ, Miller WH, Jurisson S, Boote E, Robertson JD, Cutler C, Dobrovolskaia M, Kannan R, Katti KV.

Nanomedicine. 2010 Apr;6(2):201-9. doi: 10.1016/j.nano.2009.11.001. Epub 2009 Nov 12.

PMID:
19914401

Supplemental Content

Support Center